Pharmaceutical industry
Identification of Novel Allosteric Modulators for FFA2 Receptor
Scientists in the United States have discovered a series of small molecule phenylacetamides that serve as novel and more potent FFA2 agonists. These compounds are specific for FFA2 over FFA1 and FFA3 and can activate both the G alpha(q) and G alpha(i) pathways in vitro. Treatment of adipocytes